CoChat
Sign Up
Cited by 67

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells

Timper, Katharina, Dalmas, Elise, Dror, Erez, Rütti, Sabine, Thienel, Constanze, Sauter, Nadine S., Bouzakri, Karim, Bédat, Benoit, Pattou, Francois, Kerr-Conte, Julie, Böni-Schnetzler, Marianne, Donath, Marc Y.·2016·Gastroenterology
DOI 10.1053/j.gastro.2016.03.003
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2016.03.003

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 13 references

Research works printed but not linked: 31

  1. Svendsen, 2016, Regulation of gut hormone secretion. Studies using isolated perfused intestines, Peptides, 77, 47, 10.1016/j.peptides.2015.08.001 · DOI
  2. Rouille, 1997, Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1, J Biol Chem, 272, 32810, 10.1074/jbc.272.52.32810 · DOI
  3. Rouille, 1995, Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide, J Biol Chem, 270, 26488, 10.1074/jbc.270.44.26488 · DOI
  4. Marchetti, 2012, A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets, Diabetologia, 55, 3262, 10.1007/s00125-012-2716-9 · DOI
  5. Ellingsgaard, 2011, Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells, Nat Med, 17, 1481, 10.1038/nm.2513 · DOI · Paper page
  6. Ehses, 2003, Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase, Endocrinology, 144, 4433, 10.1210/en.2002-0068 · DOI
  7. Seino, 2013, Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas, J Diabetes Investig, 4, 108, 10.1111/jdi.12065 · DOI
  8. Fujita, 2010, Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion, Gastroenterology, 138, 1966, 10.1053/j.gastro.2010.01.049 · DOI
  9. Holst, 2011, Regulation of glucagon secretion by incretins, Diabetes Obes Metab, 13, 89, 10.1111/j.1463-1326.2011.01452.x · DOI
  10. Roberge, 1993, Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop, Endocrinology, 133, 233, 10.1210/endo.133.1.8319572 · DOI
  11. Hansen, 2002, The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno–ileal loop?, Regul Pept, 110, 39, 10.1016/S0167-0115(02)00157-X · DOI
  12. Vilsboll, 2003, The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype, J Clin Endocrinol Metab, 88, 4897, 10.1210/jc.2003-030738 · DOI
  13. Vilsboll, 2002, Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients, Diabetologia, 45, 1111, 10.1007/s00125-002-0878-6 · DOI · Paper page
  14. Chia, 2009, Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes, Diabetes, 58, 1342, 10.2337/db08-0958 · DOI
  15. Donath, 2014, Targeting inflammation in the treatment of type 2 diabetes: time to start, Nat Rev Drug Discov, 13, 465, 10.1038/nrd4275 · DOI · Paper page
  16. Suzuki, 2011, Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway, Diabetes, 60, 537, 10.2337/db10-0796 · DOI
  17. Ellingsgaard, 2008, Interleukin-6 regulates pancreatic alpha-cell mass expansion, Proc Natl Acad Sci U S A, 105, 13163, 10.1073/pnas.0801059105 · DOI · Paper page
  18. Ehses, 2007, Increased number of islet-associated macrophages in type 2 diabetes, Diabetes, 56, 2356, 10.2337/db06-1650 · DOI
  19. Boni-Schnetzler, 2008, Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation, J Clin Endocrinol Metab, 93, 4065, 10.1210/jc.2008-0396 · DOI
  20. Malaisse, 1984, Forskolin-induced activation of adenylate cyclase, cyclic adenosine monophosphate production and insulin release in rat pancreatic islets, Endocrinology, 115, 2015, 10.1210/endo-115-5-2015 · DOI
  21. Bonner, 2015, Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion, Nat Med, 21, 512, 10.1038/nm.3828 · DOI · Paper page
  22. Malmgren, 2015, DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice, Diabetologia, 58, 1091, 10.1007/s00125-015-3518-7 · DOI
  23. Wang, 2003, Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter, J Biol Chem, 278, 32899, 10.1074/jbc.M305456200 · DOI
  24. Hansen, 2011, Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus–an adaptive response to hyperglycaemia?, Diabetologia, 54, 1379, 10.1007/s00125-011-2080-1 · DOI
  25. Fernandez-Millan, 2013, Role of endogenous IL-6 in the neonatal expansion and functionality of Wistar rat pancreatic alpha cells, Diabetologia, 56, 1098, 10.1007/s00125-013-2862-8 · DOI
  26. Shirazi, 2013, Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6, Proc Natl Acad Sci U S A, 110, 16199, 10.1073/pnas.1306799110 · DOI
  27. Amland, 1985, Effect of intravenously infused porcine GIP on serum insulin in obese and lean subjects studied with the hyperglycemic clamp technique, Scand J Gastroenterol, 20, 309, 10.3109/00365528509091656 · DOI
  28. Maedler, 2002, Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets, J Clin Invest, 110, 851, 10.1172/JCI200215318 · DOI
  29. Aaboe, 2015, Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors, Diabetes Obes Metab, 17, 74, 10.1111/dom.12395 · DOI
  30. Hojberg, 2009, Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes, Diabetologia, 52, 199, 10.1007/s00125-008-1195-5 · DOI · Paper page
  31. Timper, 2015, Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus, J Diabetes Complications, 29, 955, 10.1016/j.jdiacomp.2015.05.019 · DOI

Cited by

Sorted by citations

See all 67

Metadata

Authors
Timper, K., Dalmas, E., Dror, E., Rütti, S., Thienel, C., Sauter, N. S., Bouzakri, K., Bédat, B., Pattou, F., Kerr-Conte, J., Böni-Schnetzler, M., & Donath, M. Y.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2016-07
Volume
151
Issue
1
Pages
165-179
ISSN
0016-5085
DOI
10.1053/j.gastro.2016.03.003
Cited by
67
References
13
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review